Central corticotropin releasing hormone (CRH)-induced activation of the sympathetic nervous system and/or the pituitary-adrenal axis is hypothesized to mediate suppression of in vivo specific antibody responses. To test whether β-adrenergic receptor activation is involved in the immunosuppressive effects of central CRH, rats were pretreated with propranolol or saline before intracerebroventricular infusion of CRH and immunization with keyhole limpet hemocyanin (KLH). KLH (3 µg/kg) immunization induced significant increases in circulating levels of antigen-specific IgM and IgG. Central infusion of CRH (200 pmol) suppressed both IgM and IgG responses. Pretreatment with propranolol (20 mg/kg IP) reversed CRH-induced suppression of IgG responses but had no effect on IgM levels. To test whether adrenal activation also plays a role in the effects of KLH on specific antibody responses, a separate group of animals underwent adrenalectomy prior to CRH infusion and immunization with KLH. As compared to nonadrenalectomized control rats, adrenalectomized rats showed a reduction of antibody responses, and CRH failed to induce a further suppression of IgM or IgG responses in adrenalectomized animals. Collectively, these data suggest that β-adrenoceptors mediate the suppression of primary antibody responses induced by central CRH. Moreover, the adrenals may promote optimal primary antibody responses after exposure to physiological levels of antigen.
INTRODUCTION
Corticotropin-releasing hormone (CRH) is released during stress and acts within the brain to coordinate visceral and behavioral responses to stress (Britton, Koob, Rivier, & Vale, 1982; Britton, Lee, Vale, Rivier, & Koob, 1986; Brown & Fisher, 1985; Sutton, Koob, LeMoal, Rivier, & Vale, 1982) . Elevated concentrations of CRH in the brain are also associated with marked alterations of in vitro correlates of natural and cellular immune function; intracerebroventricular (ICV) infusion of CRH significantly reduces ex vivo measures of immune function such as mitogen-induced lymphocyte proliferation and natural killer (NK) cytotoxicity in rats (Irwin, Hauger, Brown, & Britton, 1988; Irwin, Hauger, Jones, Provencio, & Britton, 1990; Irwin, Vale, & Rivier, 1990; Jain et al. 1991; Strausbaugh & Irwin 1992) . In vivo immune function, as measured by specific IgM and IgG production following immunization with keyhole limpet hemocyanin (KLH), is also reduced following ICV CRH administration (Irwin, 1993) .
There is now considerable evidence suggesting that the sympathetic nervous system mediates many immunosuppressive effects of centrally acting CRH. Postganglionic blockade, nonselective β1-β2-, or selective β2-adrenergic receptor antagonism have been shown to abrogate the reduction of splenic NK activity following central infusion of CRH (Irwin, Hauger, Jones, Provencio, & Britton, 1990; Irwin, Hauger, 
